Labcorp releases transcript of Q2 2026 earnings call webcast prepared remarks
Reuters2026/07/30 13:36- Labcorp’s Q2 2026 results webcast drew Chairman and CEO Adam Schechter, CFO Julia Wang, SVP IR Dewey Steadman.
- Q2 revenue rose 6% to USD 3.7 billion; adjusted operating margin widened 70 bps to 15.8%; adjusted EPS increased 15% to USD 4.99.
- Diagnostics revenue grew 5.5% to USD 2.9 billion; adjusted operating margin improved to 18% from 17.6%.
- Biopharma Laboratory Services revenue climbed 6.5% to USD 836 million; margin expanded to 17% from 15.7%; book-to-bill 1.14; backlog USD 8.7 billion.
- Raised 2026 guidance: revenue growth 5.4%-6.3%; adjusted EPS USD 18.10-18.55; free cash flow USD 1.24-1.36 billion; buyback authorization lifted by USD 1 billion to USD 1.4 billion.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
NVE Director Daniel A. Baker disposes of 21,140 shares worth $2.15 million
CleanSpark CTO, COO Taylor Monnig disposes of USD 1.83 million in common shares
Bank of America: Nvidia and Broadcom have the widest holdings, with Micron and AMD significantly added by actively managed funds
Bank of America stated that among active fund managers in the United States, Nvidia and Broadcom hold the "widest" position base in the semiconductor sector, while the holding proportions of Micron Technology and AMD have also seen significant increases.
Terawulf director Catherine J. Motz disposes of 56,023 common shares worth USD 997,976.18
Crypto prices
More
